Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Early diagnosis and thorough evaluation are crucial for better outcomes in alopecic sarcoidosis.

Early diagnosis and treatment of EGFR inhibitor-induced folliculitis decalvans can prevent permanent hair loss.

Alopecia Areata can affect nails, often improving on its own, but JAK inhibitors may help.

Osteoma cutis is a rare, benign skin condition where bone forms in the skin.

Adipose tissue-derived exosomes may help treat lichen planopilaris and preserve hair.

Rosemary oil may effectively treat hair loss with fewer side effects, but more research is needed.

Non-scarring hair loss is common in lupus patients and can be diagnosed with specific hair and tissue tests.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Blocking a protein called CXXC5 with a specific peptide can stimulate hair regrowth and new hair growth in wounds.

Minoxidil can cause a skin reaction called ALEP.

Alopecia areata is an autoimmune disease causing hair loss, treatable with immune-modulating drugs, and linked to genetics.

PPAR-γ agonists like pioglitazone may help manage lichen planopilaris but don't fully reverse scarring.

The study concluded that similar pathways regulate hair growth in dogs and mice, and these pathways are disrupted in dogs with Alopecia X, affecting stem cells and hormone metabolism.

Injecting a cell suspension from hair follicles increased hair density in a balding patient.

Secondary syphilis in Cali, Colombia, shows high Treponema pallidum presence and challenges in early diagnosis, needing better public health strategies.

Congenital atrichia with papular lesions is often misdiagnosed, and new diagnostic criteria can improve accuracy.

Peptides, proteins, and growth factors in skincare show promise for improving skin health.

Long COVID-19 patients with skin pain might have a nerve condition that responds to a medication called gabapentin.

New regenerative treatments show promise in improving hair growth for androgenetic alopecia.

Higher substance P levels may cause discomfort in hair loss patients.

Alopecia areata causes significant emotional and social challenges, especially with more hair loss.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

Androgenetic alopecia, or hair loss, is caused by a mix of genetics, hormones, and environment, where testosterone affects hair growth and causes hair to become smaller and grow for a shorter time.

Hair loss can be managed with treatments like minoxidil, finasteride, and others, but there are still gaps in effectiveness and off-label usage is increasing.

Extracellular vesicles show promise in skin treatments but need more research and standardization.

There is no gold standard treatment for hidradenitis suppurativa due to insufficient evidence.

A man developed a rare skin condition after a hair transplant surgery.

Soy supplements improve various skin conditions and aging signs, with topical use boosting skin barrier function.

The serum improves facial skin quality safely and effectively.